Pre-Tax Income: Company's earnings or loss before taxes on income have been accounted for.
Liminatus Pharma Inc. (LIMN) had Pre-Tax Income of $0.00M for the most recently reported fiscal quarter, ending 2025-03-31.
| Income Statement Financials | |
-- |
|
$-0.00M |
|
-- |
|
-- |
|
$-0.00M |
|
$0.00M |
|
-- |
|
|
Pre-Tax Income |
$0.00M |
$0.00M |
|
$0.00M |
|
$0.00M |
|
$0.00M |
|
$0.00M |
|
$0.00M |
|
$0.00M |
|
0.00M |
|
0.00M |
|
$-2.55 |
|
$-2.55 |
|
| Balance Sheet Financials | |
-- |
|
-- |
|
-- |
|
$0.00M |
|
$0.00M |
|
-- |
|
-- |
|
$0.00M |
|
$-0.00M |
|
$-0.00M |
|
$-0.00M |
|
0.00M |
|
| Cash Flow Statement Financials | |
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|